NEWS
You can follow the latest news of MicroViable in this section
Microviable will be attending Bio€quity Europe. San Sebastián
Claudio Hidalgo Cantabrana, CEO at Microviable Therapeutics, and our CBO, Rafael Permuy, will be attending Bio€quity Europe event in San Sebastián (Spain) from May 12th to 14th and May 21, 22 (virtual). Microviable Team joins [...]
Past, present, and future of microbiome-based therapies
Technological advances in studying the human microbiome in depth have enabled the identification of microbial signatures associated with health and disease. This confirms the crucial role of microbiota in maintaining homeostasis and the host health [...]
Inmunobiota: A co-creation project of Microviable and the Institute of Catalysis and Petroleochemistry (ICP-CSIC)
Inmunobiota is one of the projects selected in CSIC-COCREA that seeks to develop products based on microbiota to combat infections and enhance the immune response. THE CHALLENGE Immunotherapy has improved the prognosis of lung cancer, [...]
International Childhood Cancer Day 2024
Today, February 15, is International Childhood Cancer Day (ICCD), a global collaborative campaign to raise awareness about childhood cancer and to express support for children and adolescents with cancer, the survivors, and their families. In [...]
International Day of Women and Girls in Science 2024
From Microviable in the International Day of Women and Girls in Science, we want to speakup for all the female working in STEM (Science, Technology, Engineering and Mathematics), not only for their great work but [...]
Microviable chosen among the hundred most outstanding startups in 2023
Microviable Therapeutics, a biotechnology company dedicated to the development of new biotherapeutic products based on intestinal microbiota and established in the Gijón Scientific and Technological Park, has been chosen by the Association of Scientific and [...]